SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-24-003731
Filing Date
2024-02-20
Accepted
2024-02-20 17:25:33
Documents
17
Period of Report
2024-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 18426
2 EXHIBIT 1.1 exhibit1-1.htm EX-1.1 108785
  Complete submission text file 0001062993-24-003731.txt   373567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20240214.xsd EX-101.SCH 4469
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20240214_cal.xml EX-101.CAL 694
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20240214_def.xml EX-101.DEF 22200
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20240214_lab.xml EX-101.LAB 46376
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20240214_pre.xml EX-101.PRE 24829
19 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 2956
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31187 | Film No.: 24655056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)